Comparison of a DNA Based PCR Approach with Conventional Methods for the Detection of Mycobacterium tuberculosis in Morocco

Fathiah Zakham1,2,3, Oufae Lahlou1,  Mohammed Akrim1, Nada Bouklata1,  Sanae Jaouhari1, Khalid Sadki1,3, Fouad Seghrouchni1, Mohammed Elmzibri4, Abdelaziz Benjouad3, My Mustapha Ennaji2*+ and Rajae Elaouad1+

1 Institut National d’Hygine, Rabat, Morocco.
2 Laboratoire de Virologie et Hygine & Microbiologie, Facult des Sciences et Techniques. Mohammedia, Morocco.
3 Laboratoire de Biochimie et Immunologie, Facult des Sciences. Universit Mohammed V-Agdal. Rabat. Morocco.
4 Unit de Biologie et Recherches Mdicales, Centre National de l’Energie, des Sciences et Techniques Nuclaires- Rabat- Morocco.

+ My M. ENNAJI and R. ELAOUAD share senior authorship in this study (equal contribution).

Correspondence to: Pr. My Mustapha Ennaji, University Hassan II. Mohammedia-Casablanca. Faculty of Sciences and Techniques, Mohammedia-Casablanca. Laboratory of Virology, Hygiene & Microbiology,  BP 146, Mohammedia, (20650), Morocco. Tel: +212661748862/ 212662013772, Fax: 212523315353. E-mail:

Published: August 9,  2012
Received: April 30, 2012
Accepted: July 9, 2012
Meditter J Hematol Infect Dis 2012, 4(1): e2012049, DOI 10.4084/MJHID.2012.049
This article is available on PDF format at:
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited


Background: Worldwide, tuberculosis (TB) is a major public health problem and the rapid diagnosis and appropriate chemotherapy become the first priority and a serious challenge to improve TB treatment. In the objective of early TB diagnosis and rapid detection of Mycobacterium tuberculosis (MTB) in the clinical specimens, the utility of the Polymerase Chain Reaction (PCR) using the Insertion Sequence 6110 “IS6110" as target was compared to conventional methods.
Methods: Out of 305 patients with different clinical manifestations: suspected, new, drug relapse, drug failure and chronic cases were enrolled in this study and tested by mycobacteriological and PCR techniques for the investigation about the tubercle bacilli.
Results: The results of the in house “IS6110" PCR showed a good sensitivity (92.4%) and high specificity (98.0%), the positive and negative predictive values were 96.4 % and 95.3 % respectively.
Conclusion: This study showed clearly that the PCR testing using the “IS6110" in the routine analysis is a potential tool for the rapid TB diagnosis, especially for critical cases and would be of great interest to help the clinician in the misdiagnosed critical cases by the traditional radiology.

Mycobacterium tuberculosis (MTB) is the causative agent of Tuberculosis (TB), which is responsible for 8 to 10 million new cases of TB and 2 million deaths annually.[1] In Morocco, TB is a major problem of the public health with a high incidence reaching 82.1 new cases for 100 000 inhabitants.[2] Tuberculosis affects especially young adults and therefore has a high impact on the socio-economic status of the country.
The early and rapid diagnosis of MTB is very important for controlling and initiation drug treatment regimen. The laboratory diagnosis of TB is mainly based on the microscopic examination by the Ziehl-Neelsen staining and MTB culture, which are widely used in the laboratories of public health centers for the routine analysis.[3,4] Ziehl-Neelsen staining is a cheap technique and easy to perform but lacks sensitivity and is unable to distinguish between MTB members and other atypical mycobacteria. Moreover, Ziehl-Neelsen staining can only detect acid-fast bacilli in concentrations exceeding 10,000 organisms per ml.[5] MTB culture is the gold standard method but it requires viable microorganisms and long time incubation (up to 4 weeks), representing a problem especially for patients with critical situations such as immunocompromised or AIDS patients.
To overcome these limitations, molecular approaches have been introduced into clinical mycobacteriology laboratories. In this field, the most common technique used is the DNA amplification by the Polymerase Chain Reaction (PCR). The opportunity to use PCR for the detection of MTB in clinical samples has been reported.[7-9] Many MTB DNA sequences; including 16S rDNA and hsp65 genes and “IS6110" are used as targets for MTB detection by PCR.[10-12]
The insertion sequence “IS6110" is a transposable element which is present in the members of MTB complex in multiple copies (up to 25 copies), except M. bovis BCG which harbours a single copy and absent in other mycobacteria.[13,14] For those reasons the insertion sequence “IS6110” has been reported as the most common target used for the MTB diagnosis in the clinical samples and demonstrated that the detection rate of MTB complex targeting “IS6110” was higher than that of microscopy or MTB culturing with a considerable time.[7,12,15,16] Furthermore, due to its high numerical and positional polymorphism, “IS6110"  sequence has become a widely used marker in the epidemiological studies[17,18] and the fingerprinting of this transposable element has been used for the strain identification[19] and phylogenetic analysis.[14] Consequently, “IS6110" sequence is a useful and reliable tool for the diagnosis of mycobacterial strains in clinical specimens.[20-22] Thus, this study was planned to evaluate the use of PCR for “IS6110" sequence amplification for rapid diagnosis of MTB in clinical samples to improve the TB management in Morocco.

Materials and Methods
Sampling. A total of 305 specimens were collected from different hospitals in and around Rabat city and sent to the National laboratory of Reference in Tuberculosis (LNRT) at the National Institute of Hygiene in Rabat for MTB detection from February 2010 to May 2011.
Patients have been classified to five groups according to their clinical manifestations: suspected, new, treatment failure, treatment relapse and chronic TB cases depending on the symptoms and radiological examination. The suspected cases were sent to LNRT for an initial assessment of TB. The new cases were sent to confirm the infection with MTB, without undergoing to any drug treatment regimen.
Patients suffering of drug failure or relapse and chronic cases don’t show any improvement in their health even with treatment after six months and they are still having TB profile in their radiological examination.
Most of the specimens were pulmonary (sputum, sputum induced by fibre-optic bronchoscopy, bronchial wash and bronchial aspirations), and some of them were extrapulmonary (pleural fluid, abscess, urine and gastric liquid).
All the pulmonary specimens were decontaminated and liquefied with N-acetyl-l-cysteine (NALC) method,[23] the biopsy was minced, homogenized in a sterile homogenizer and concentrated. The rest of specimens were concentrated by centrifugation as mentioned by Ben Kahla et al,[24] the inoculation was performed on Lowenstein Jensen (L/J). A part of each decontaminated specimen was sent to the Molecular biology laboratory for MTB detection by PCR.

Bacterial lysis.
Bacterial lysis was performed as described by Aldous, et al.[25] Briefly, the specimen was first thawed and centrifuged at 6,000 g for 1 min. The supernatant was discarded and the pellet was resuspended in 200 l of TE buffer and processed in boiling water bath for 15 min to inactivate bacteria and release DNA. After centrifugation at 16,000 g for 5 min, aliquot of 100 μl of the supernatant was transferred to a sterile tube. DNA was immediately used for PCR amplification or stored at -20C until use.

PCR for amplification of the insertion sequence IS 6110. The primers 5'-CCTGCGAGCGTAGGCGTCGG-3' and 5'-CTCGTCCAGCGCCGCITCGG-3',   were used to amplify a 123-base-pair fragment as described by Eisenach, et al.[20] The amplification reaction was performed in a total volume of 50 l of the amplification mixture contained 0.2 M of each primer, 0.2 mM of each dNTPs, 2.5 mM MgCl, 5 Units of Taq DNA polymerase enzyme (Roche diagnostic, GmbH, Manheim, Germany) and 3 l of DNA sample in 1x Taq polymerase buffer.
PCR reactions were performed in thermal cycler (Gene Amp, PCR system 9700, Applied Bio system). The mixture was first denatured at 95C for 10 min. Then, 40 cycles of PCR were performed with denaturation at 95C for 1 min, primer annealing for 1 min at 68C and primer extension for 1 min at 72C. At the end of the last cycle, the mixture was incubated at 72C for 10 min. For every reaction a negative control, in which DNA template was omitted from the amplification mixture, and a positive control, containing DNA from H37Rv MTB strain are included. PCR products were analyzed by electrophoresis on 2% agarose gels followed by staining with ethidium bromide (10 mg/ml).

Statistical analysis.
Specificity, sensitivity, positive and negative predictive values were calculated were calculated in combination with the bacterial culture, as a gold standard technique.[26] For testing the agreement between culture and molecular approach, the kappa index was applied.[27]

A total of 305 specimens were enrolled in this study. The demographical and epidemiological information about the patients were assessed by a questionnaire regarding (range of age, age median, percentage of each sex and sex ratio) are summarized in Table 1 and showed that the age medians of the different groups were forties with a significant male predilection. The results of mycobacteriological examination and PCR testing according to their clinical manifestation are also outlined in Table 1. Among the 305 specimens, positive results were obtained in 75, 116 and 111 cases by direct examination, culture and PCR respectively.
The results showed that culture is more sensitive than the direct examination in detection of MTB in all groups of cases. Furthermore, the results of conventional examination and Molecular testing according to the kind of specimens are summarized in Table 2.
Comparison of results obtained by direct examination with the molecular approach is reported in Table 3 and showed a significant difference. In fact, for 43 smear negative cases, the presence of MTB DNA was revealed by PCR.
Seven smear positive with low number of seen acid fast bacilli AFB were negative by PCR approach. Moreover, among the 305 specimens, 187 were negative by Ziehl Nielsen and PCR, and 68 were positive by direct examination and confirmed by PCR testing.
Comparison of MTB detection in the 305 specimens by both culture and PCR is reported in Table 4. Similar results were obtained for 292 clinical specimens. A total of 107 cases were positive by both MTB culture and PCR testing, and 185 cases were MTB negative by culture and confirmed by PCR. However, discordance was obtained for 13 cases. A total of 9 samples were positive in culture and negative in PCR. Four samples were positive by PCR and negative in culture; with strong sever symptoms of clinical manifestations of TB as reported in the clinical data. Among these 4 samples, two were positive in the direct microscopic examination but in low numbers of acid fast bacilli (AFB).

Table 1
. The demographical, epidemiological information about the patients and the results of conventional and molecular techniques.

Table 2.
The results of conventional examination and PCR according to the kind of specimen.

Table 3.
Comparison of MTB detection by the direct microscopy smear and molecular techniques.

Table 4. Comparison of MTB detection by culture and molecular techniques.

Depending on these results, specificity and sensitivity of the direct PCR compared to the culture as “gold standard” were calculated of the 305 clinical samples. Therefore, the PCR technique has a good sensitivity (92.6 %) and high specificity (98.0 %). The positive and negative predictive values were 96.4 % and 95.3 % respectively.
Moreover, the  statistical  test  for  the  accordance between PCR and culture was expressed by kappa index with an excellent agreement of 0.9088.

The diagnosis of tuberculosis poses a major problem and a serious challenge, especially in countries with limited resource, including Morocco. On the international scale, the TB management remains a nightmare and the early diagnosis of MTB and drug resistance testing confront a great defy and a high challenge, particularly in the paucibacillary specimens such smear negative sputum, biopsies, pus and body fluids.[28] Classical radiography still the first step of diagnosis after the suspicion of TB by the clinical manifestation, but it is not specific for the detection of MTB, and merely the identification of the microorganism in the specimens can confirm the diagnosis.[4] Most of people in critical cases are usually elder, aged between 48 to 80 years and probably suffering from other underlying diseases rather than TB and can show atypical clinical presentation of TB.[3] Furthermore, it was unexpected to misdiagnose a lot of cases as chronic, drug relapse or drug failure according to their clinical history.
Currently, the laboratory diagnosis of TB is based on the conventional techniques, including the method of Ziehl-Neelsen staining which lacks sensitivity and MTB culture that is time consuming.[5,6] In this study, the MTB culture provided high sensitivity in comparison with the direct examination, 116 in culture versus 75 with smear microscopy. These results are in agreement with the worldwide use of MTB culture as a “gold standard” technique.[3]
The implementation of reliable and rapid molecular techniques for the detection of TB strains is likely to be necessary to improve health surveillance of TB. Therefore, this study was done to evaluate the utility of the molecular approach based on PCR testing to detect MTB DNA directly from clinical specimens. Many studies have evaluated the detection of limited mycobacteria cells, from clinical specimens, by PCR technique targeting different sequences such as 16S rDNA and hsp65 genes, and “IS6110". The 16S rDNA gene is one of the most used genes for this purpose,[10] but its utilization is limited by the need of PCR product sequencing. Moreover, PCR targeting 16S rDNA gene cannot differentiate between the closely related species of mycobacteria.[10] The hsp65 was also reported to be used as a target for PCR testing to detect MTB DNA in clinical cases, but the necessity of sequencing is still mandatory for the differentiation between the complex MTB and other non tuberculosis mycobacteria.[11,29]
The insertion sequence “IS6110" which exists only in MTB complex members, is the most used target for the mycobacterial DNA amplification[7,12,20] and is the standard marker for the epidemiologic studies of TB. Moreover, the “IS6110" is a potential tool to differentiate between the members of MTB complex and other non tuberculosis and atypical mycobacteria.[18,21,30] In this context, it is noteworthy to mention that the IS1081 has also been used for the detection of MTB complex in the paucibacillary specimens.[31]
The results obtained in each group of patients according to their TB profile do not show a significant difference between culture and PCR. In fact, TB profile depends especially on the virulence of the bacteria and the immunity of the patient, and could be a consequence of drug failure or abandon of treatment. But, bacterial culture and PCR testing rest on the presence of viable cells and bacterial DNA respectively.
The corner stone of this study is the rapid detection of MTB in the clinical specimens by molecular approach among critical MTB cases. Thus, Among the 305 tested cases, 107 strains were detected by PCR with high positive and negative predictive values. When comparing the results obtained by PCR with the direct microscopic examination, a wide gap was found (75 detected by the direct examination versus 111 positive by PCR). The 7 positive smears and negative by PCR were recorded with low numbers of AFB and were also negative by culture. Indeed, the culture requires viable microorganisms and this is a huge problem especially in people under chemotherapy. Moreover, it’s widely accepted that the detection limit of PCR is generally 10 mycobacterial genome copies; the sputum samples with a score of AFB 1+ may contain smaller amounts of required DNA to be amplified.[32] On the other hand, MTB DNA from 43 specimens smear negative was detected by PCR, giving a clear evidence of the utility of PCR testing to enhance direct detection of MTB.
The comparison of PCR testing to the “Gold standard” technique gives a high sensitivity (98%) and good specificity (92.6 %) and the agreement between PCR and culture was 0.9088, which is an excellent value. The specificity and sensitivity of detection of MTB from clinical specimens by PCR are in concordance with the results obtained in Tunisia using the same insertion sequence[24] and with other studies that also documented the use of the “IS6110" for the direct diagnosis of TB with reliable results comparing to traditional techniques.[15,16] The false-negative results (9 specimens were positive in culture and negative in PCR) can be ascribed either to the paucibacillary nature of the specimen, inefficient extraction of the DNA or the presence of PCR inhibitors.[28]
Moreover some of these strains could lack the insertion sequence “IS6110" as reported by El Baghdadi et al. in some strains isolated in Morocco.[33]
Thus, the use of PCR targeting the insertion sequence “IS6110" in the routine analysis for the detection of MTB, will be of great interest for the diagnosis of TB, especially in the critical cases, such as chronic and treatment failure or relapse cases, where the rapid diagnosis is mandatory for the initiation of chemotherapy. Furthermore, for most accuracy it could be better to make a combination between clinical, radiological, bacteriological and PCR testing to confirm the presence of the MTB for a better management of TB in Morocco.

This study has been partially funded by the Academie Hassan II des Sciences & Techniques in Morocco.


  1. WHO R: Global Tuberculosis Control: epidemiology, strategy, financing WHO/ HTM/TB/ 2010. 300. WHO Report 2010.  
  2. Direction de l’pidmiologie et de lutte contre les maladies DELM: Tuberculosis in Morocco. In Epidemiologic bulletin, vol. N:69-70-71-72. pp. 32-33; 2007:32-33. 
  3. Lange C, Mori T: Advances in the diagnosis of tuberculosis. . Respirology 2010, 15:220–240. PMid:20199641 
  4. Davies PDO, Pai M: The diagnosis and misdiagnosis of tuberculosis [State of the art series. Tuberculosis. Edited by I. D. Rusen. Number 1 in the series]. The International Journal of Tuberculosis and Lung Disease 2008, 12:1226-1234. PMid:18926032 
  5. Yeager H, Lacy JJ, Smith L, Le Maistre C: Quantitative studies of mycobacterial populations in sputum and saliva. Am Rev Respir Dis 1967, 95:998-1004. PMid:4961042 
  6. Hobby GL, Holman AP, Iseman MD, Jones JM: Enumeration of Tubercle Bacilli in Sputum of Patients with Pulmonary Tuberculosis. Antimicrobial Agents and Chemotherapy 1973, 4:94-104. PMid:4208508 PMCid:444512 
  7. Takahashi T, Tamura M, Takahashi SN, Matsumoto K, Sawada S, Yokoyama E, Nakayama T, Mizutani T, Takasu T, Nagase H: Quantitative nested real-time PCR assay for assessing the clinical course of tuberculous meningitis. Journal of the neurological sciences 2007, 255:69-76. PMid:17350048 
  8. Rebollo MaJ, San Juan Garrido R, Folgueira D, Palenque E, Daz-Pedroche C, Lumbreras C, Aguado JM: Blood and urine samples as useful sources for the direct detection of tuberculosis by polymerase chain reaction. Diagnostic microbiology and infectious disease 2006, 56:141-146.  PMid:16698218 
  9. Yam WC, Cheng VCC, Hui WT, Wang LN, Seto WH, Yuen KY: Direct detection of Mycobacterium tuberculosis in clinical specimens using single-tube biotinylated nested polymerase chain reaction-enzyme linked immunoassay (PCR-ELISA). Diagnostic microbiology and infectious disease 2004, 48:271-275.  PMid:15062920 
  10. Nakano N, Wada R, Yajima N, Yamamoto N, Wakai Y, Otsuka H, : Mycobacterial infection of the musculoskeletal tissues: the use of pathological specimens for identification of causative species by PCR-direct sequencing of 16S rDNA. Jpn J Infect Dis 2010, 63:188-191. PMid:20495271 
  11. Kim K, Lee H, Lee M-K, Lee S-A, Shim T-S, Lim SY, Koh W-J, Yim J-J, Munkhtsetseg B, Kim W, et al: Development and Application of Multiprobe Real-Time PCR Method Targeting the hsp65 Gene for Differentiation of Mycobacterium Species from Isolates and Sputum Specimens. Journal of Clinical Microbiology 2010, 48:3073-3080.  PMid:20631094 PMCid:2937694 
  12. Eisenach KD, Crawford JT, Bates JH: Repetitive DNA sequences as probes for Mycobacterium tuberculosis. Journal of Clinical Microbiology 1988, 26:2240-2245. PMid:3148630 PMCid:266867 
  13. Thierry D, Cave MD, Eisenach KD, Crawford JT, Bates JH, Gicquel B, Guesdon JL: IS6110, an IS-like element of Mycobacterium tuberculosis complex. Nucleic Acids Research 1990, 18:188.  PMid:2155396 PMCid:330226 
  14. Thorne N, Borrell S, Evans J, Magee J, Garcaa de Viedma D, Bishop C, Gonzalez-Martin J, Gharbia S, Arnold C: IS6110-based global phylogeny of Mycobacterium tuberculosis. Infection, Genetics and Evolution 2011, 11:132-138.  PMid:20920607 
  15. Abraham P, Sharma V, Shivannavar C: Diagnosis of TB from smear & culture negative sputum specimens by IS 6110 based PCR. Indian J Med Res 2012;135: 2012, 135:249-251. 
  16. Ani A, Okpe S, Akambi M, Ejelionu E, Yakubu B, Owolodun O, Ekeh P, Oche A, Tyen D, Idoko J: Comparison of a DNA based PCR method with conventional methods for the detection of M. tuberculosis in Jos, Nigeria. J Infect Dev Ctries 2009, 3:470-475. 
  17. McEvoy CRE, Falmer AA, van Pittius NCG, Victor TC, van Helden PD, Warren RM: The role of IS6110 in the evolution of Mycobacterium tuberculosis. Tuberculosis (Edinburgh, Scotland) 2007, 87:393-404.  PMid:17627889 
  18. Mazurek GH, Cave MD, Eisenach KD, Wallace RJ, Bates JH, Crawford JT: Chromosomal DNA fingerprint patterns produced with IS6110 as strain-specific markers for epidemiologic study of tuberculosis. Journal of Clinical Microbiology 1991, 29:2030-2033. PMid:1663520 PMCid:270253 
  19. van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, Hermans P, Martin C, McAdam R, Shinnick TM: Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. Journal of Clinical Microbiology 1993, 31:406-409. PMid:8381814 PMCid:262774 
  20. Eisenach K, Cave M, Bates J, Crawford J: Polymerase chain reaction amplification of a repetitive DNA sequence specific for Mycobacterium tuberculosis. . J Infect Dis 1990, 161:977-981.  PMid:2109022 
  21. Thierry D, Brisson Noel A, Vincent-Levy-Frebault V, Nguyen S, Guesdon J, Giquel B: Characterization of a Mycobacterium tuberculosis Insertion Sequence, IS6110, and Its Application in Diagnosis. J Clin Microbiol 1990, 28 2668-2673. PMid:2177747 PMCid:268253 
  22. Sekar B, Selvaraj L, Alexis A, Ravi S, Arunagiri K, Rathinavel L: The utility of IS6110 sequence based polymerase chain reaction in comparison to conventional methods in the diagnosis of extra-pulmonary tuberculosis. Indian J Med Microbiol 2008, 26:352-355. PMid:18974489 
  23. Ratnam S, Stead FA, Howes M: Simplified Acetylcysteine-Alkali Digestion-Decontamination Procedure for Isolation of Mycobacteria from Clinical Specimens. J clin Microbiol 1987, 25 1428-1432. PMid:3305557 PMCid:269240 
  24. Ben Kahla I, Ben Selma W, Marzouk M, Ferjeni A, Ghezal S, Boukadida J: Evaluation of a simplified IS6110 PCR for the rapid diagnosis of Mycobacterium tuberculosis in an area with high tuberculosis incidence. Pathologie Biologie 2011, 59:161-165.  PMid:19477082 
  25. Aldous W, Pounder J, Cloud JL, Woods G: Comparison of Six Methods of Extracting M. tuberculosis DNA from Processed Sputum for Testing by Quantitative Real-Time PCR. J Clin Microbiol 2005, 43:2471–2473.  PMid:15872286 PMCid:1153782 
  26. Piersimoni C, Scarparo C, Piccoli P, Rigon A, Ruggiero G, Nista D, Bornigia S: Performance Assessment of Two Commercial Amplification Assays for Direct Detection of Mycobacterium tuberculosis Complex from Respiratory and Extrapulmonary Specimens. Journal of Clinical Microbiology 2002, 40:4138-4142.  PMid:12409387 PMCid:139632 
  27. Almeda J, Garca A, Gonzlez J, Quint L, Ventura PJ, Vidal R, Ruf G, Martnez JA, Jimnez de Anta MT, Trilla A, Alonso PL: Clinical Evaluation of an In-House IS <i>6110</i> Polymerase Chain Reaction for Diagnosis of Tuberculosis. European Journal of Clinical Microbiology & Infectious Diseases 2000, 19:859-867.  PMid:6756909 
  28. Kox LF, Rhienthong D, Miranda AM, Udomsantisuk N, Ellis K, Van Leeuwen J, Van Heusden S, KuijperI S, Kolk AH, : A More Reliable PCR for Detection of Mycobacterium tuberculosis in Clinical Samples J Clin Microbiol 1994, 32:672-678. 
  29. Zakham F, Bazoui H, Akrim M, Lemrabet S, Lahlou O, Elmzibri M, Benjouad A, Ennaji M, Elaouad R: Evaluation of conventional molecular diagnosis of Mycobacterium tuberculosis in clinical specimens from Morocco. J Infect Dev Ctries 2012, 12:40-45. 
  30. Otal I, Martn C, Vincent-Lévy-Frebault V, Thierry D, Gicquel B: Restriction fragment length polymorphism analysis using IS6110 as an epidemiological marker in tuberculosis. Journal of Clinical Microbiology 1991, 29:1252-1254. PMid:1677943 PMCid:269979 
  31. Taylor GM, Worth D, Palmer S, Jahans K, Hewinson RG: Rapid detection of Mycobacterium bovis DNA in cattle lymph nodes with visible lesions using PCR. BMC Veterinary Research 2007, 3:12.  PMid:17567891 PMCid:1904440 
  32. Wu T, Chia J, Kuo A, Su L, Wu T, Lai H: Rapid identification of mycobacteria from smear-positive sputum samples by nested PCR-restriction fragment length polymorphism analysis. J Clin Microbiol 2008, 46:3591-3594.  PMid:18768657 PMCid:2576587 
  33. El Baghdadi J, Lazraq R, Benani A, Naciri M, Ibrahimy S, Benslimane A: PCR detection of Mycobacterium tuberculosis lacking IS 6110. Bull Soc Pathol Exot 1997, 90:303-306. PMid:9507757 

Abstract views:


Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM

Copyright (c) 2016 Mediterranean Journal of Hematology and Infectious Diseases

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


The Mediterranean Journal of Hematology and Infectious Diseases [eISSN 2035-3006] is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.
© PAGEPress 2008-2017     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185